Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites

Long-term Use of Antibiotics and Proton Pump Inhibitors Predict Development of Infections in Patients With Cirrhosis

(2015) Jacqueline G. O'Leary et al.   Clinical Gastroenterology and Hepatology

Proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhosis: An undesirable association?

(2015) Suelen A. da Silva Miozzo et al.   JOURNAL OF HEPATOLOGY

Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: A multicenter prospective study

(2015) Rubén Terg et al.   JOURNAL OF HEPATOLOGY

ipw: AnRPackage for Inverse Probability Weighting

(2015) Willem M. van der Wal et al.   Journal of Statistical Software

Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis

(2014) G. Dultz et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function

(2014) Jasmohan S. Bajaj et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

(2014) Hendrik Vilstrup et al.   HEPATOLOGY

Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites

(2013) Marie de Vos et al.   LIVER INTERNATIONAL

Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development

(2013) Hugh Watson et al.   METABOLIC BRAIN DISEASE

Recent insights into the pathogenesis of hepatic encephalopathy and treatments

(2013) Jonathan P Sturgeon et al.   Expert Review of Gastroenterology & Hepatology

Clostridium difficile-Associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis

(2012) Sailajah Janarthanan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: A meta-analysis

(2012) Abhishek Deshpande et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Increased Rate of Spontaneous Bacterial Peritonitis Among Cirrhotic Patients Receiving Pharmacologic Acid Suppression

(2011) Gati A. Goel et al.   Clinical Gastroenterology and Hepatology

Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity

(2011) Florence Wong et al.   GUT

Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites

(2011) Eun Jung Choi et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy

(2010) Ankur Gupta et al.   JOURNAL OF HEPATOLOGY

Association of Proton Pump Inhibitor Therapy With Spontaneous Bacterial Peritonitis in Cirrhotic Patients With Ascites

(2009) Jasmohan S Bajaj et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy

(2009) Jasmohan S. Bajaj et al.   HEPATOLOGY